ODR-8 is the C. elegans ortholog of Ufm1-specific protease 2 (UfSP2), a cysteine protease involved in processing the ubiquitin-like modifier Ufm1 . Despite its enzymatic classification, ODR-8’s role in GPCR trafficking is independent of its protease activity . Key features include:
Gene structure: Located on chromosome X, odr-8 includes conserved catalytic residues (Cys, His, Asp) typical of UfSP family members .
Expression: Co-expressed with ODR-4 in 12 chemosensory neurons, including AWA and ADL neurons, where it localizes to the endoplasmic reticulum (ER) .
ODR-8 partners with ODR-4 to mediate ER-to-cilia transport of odorant receptors. Key mechanisms include:
ER complex formation: ODR-8 physically interacts with ODR-4 and GPCRs (e.g., ODR-10) at the ER membrane, suggesting a chaperone-like role in receptor folding or export .
Cell autonomy: Rescue experiments show ODR-8 functions cell-autonomously; expressing odr-8 in AWA neurons restores ODR-10 ciliary localization and odorant response .
Catalytic independence: Mutating catalytic residues (Cys116, His357) does not impair ODR-8’s ability to rescue receptor trafficking defects, indicating non-proteolytic functions .
ODR-8’s interaction with ODR-4 is conserved in humans, where the ODR4 homolog binds UfSP2 . This suggests a broader role in GPCR biogenesis across species, though human UfSP2’s exact function remains unclear.
While no studies explicitly describe an "odr-8 Antibody," critical tools used to investigate ODR-8 include:
Transgenic reporters: podr-8::mCherry::odr-8 for neuronal expression profiling .
Epitope tags: HA- or GFP-tagged ODR-8 constructs for localization studies via anti-HA/GFP antibodies .
Knockout models: odr-8(ky31) mutants with premature stop codons .
Though not directly linked to antibody therapeutics, ODR-8’s role in GPCR trafficking highlights its potential as a target for modulating chemosensory signaling. The UfSP2-ODR4 complex could inform strategies for managing GPCR-related disorders in humans .